Recently, Yang et al. reported that the tumor mutation burden and neoantigen load were not associated with patient survival in HCC patients with a TP53 mutation, and they suggested that the TP53 mutation may have a unique effect on T cell infiltration [34]. This evidence concerns the gene TP53 and hepatocellular carcinoma.